Heat shock proteins in multiple myeloma

Lei Zhang; Jacqueline H.L. Fok; Faith E. Davies

doi:10.18632/oncotarget.1584

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Heat shock proteins in multiple myeloma

Lei Zhang, Jacqueline H.L. Fok and Faith E. Davies _

PDF | HTML | How to cite

Oncotarget. 2014; 5:1132-1148. https://doi.org/10.18632/oncotarget.1584

Metrics: PDF 2736 views | HTML 3330 views | ?

Abstract

Lei Zhang1, Jacqueline H.L. Fok1 and Faith E. Davies1

1 Haemato-Oncology Research Unit, Division of Molecular Pathology, Cancer Therapeutics and Clinical Studies, The Institute of Cancer Research, London, UK

Correspondence:

Faith E. Davies, email:

Keywords: heat shock proteins, multiple myeloma, protein folding, ER stress, haematology

Received: November 7, 2013 Accepted: January 17, 2014 Published: January 19, 2014

Abstract

Heat shock proteins are molecular chaperones with a central role in protein folding and cellular protein homeostasis. They also play major roles in the development of cancer and in recent years have emerged as promising therapeutic targets. In this review, we discuss the known molecular mechanisms of various heat shock protein families and their involvement in cancer and in particular, multiple myeloma. In addition, we address the current progress and challenges in pharmacologically targeting these proteins as anti-cancer therapeutic strategies

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1584

Publication Alerts

Reviews:

Heat shock proteins in multiple myeloma

Abstract